New study: Massive Aluminum levels in Autism brains, is this the smoking gun for vaccines?
“These are some of the highest values for aluminium in human brain tissue yet recorded.” — Professor Chris Exley of Keele University, discussing new findings of Aluminum levels in the brains of people with autism
BY J.B. HANDLEY November 27, 2017
STAFFORDSHIRE, England — Professor Chris Exley is a formidable scientist, which is perhaps more important than you think, because a study he published today with his colleagues in the Journal of Trace Elements in Medicine and Biology may just be the “smoking gun” to prove that vaccines are triggering autism that we’ve all been waiting for. Professor Exley is a Professor of Bioinorganic Chemistry at Keele University in Staffordshire, England. He received a Ph.D. in a subject that makes him highly qualified to author this latest paper: “the ecotoxicology of aluminium.”
His biography explains how his career has been devoted to the topic of aluminum in the brain:
“My research career (1984-present) has focussed upon an intriguing paradox; ‘how come the third most abundant element of the Earth’s crust (aluminium) is non-essential and largely inimcal to life’. Investigating this mystery has required research in myriad fields from the basic inorganic chemistry of the reaction of aluminium and silicon to the potentially complex biological availability of aluminium in humans. I am also fascinated by the element silicon in relation to living things which, as the second most abundant element of the Earth’s crust, is also almost devoid of biological function. One possible function of silicon is to keep aluminium out of biology (biota) and this forms a large part of the research in our group. We are also interested in biological silicification.”
Brand new research: How Aluminum Triggers Autism
Back in February, I wrote an extensive article that detailed emerging research, most of it published since 2010, that appeared to explain exactly how, biologically, vaccines administered to babies could be causing Autism through something known as an “Immune Activation Event.” If you haven’t yet, I respectfully ask that you consider reading that article (more than 300,000 reads so far), because Professor Exley’s findings will make even more sense to you for how important this new paper really is:
BY J.B. HANDLEY February 22, 2017healthcareinamerica.us
Big picture, newly published research is demonstrating that the following process is involved with triggering autism (please see a much more extensive explanation of this process at the bottom of this post):
Looking at this chart for a moment, the point of my article was that new published science has provided us with clear, unassailable, scientific answers at EVERY STEP of this process. We know that aluminum adjuvant from vaccines goes straight to the brain, we know it triggers the production of a cytokine known as “IL-6” that has been implicated in autism, and we know it also triggers “Microglial Activation,” which also triggers autism.
I’ll review just a few of the most recent scientific studies that help paint the picture of how autism is created, and then explain how Professor Exley’s work takes things to a new level.
In 2015, a study from Université Paris Est Créteil (UPEC) in France bolstered our understanding that the aluminum adjuvant used in vaccines is a dangerous, biopersistent, and ultimately brain-injuring toxin. (The study demonstrated that aluminum adjuvant slowly makes its way to the brain, where it then stays, possibly forever.)
The study explained that aluminum adjuvant can generate a long-term immune response because of its “biopersistence”, which basically means our body has no ability to rid itself of aluminum adjuvant, because its a man-made substance we have no natural designs to eliminate:
“Thus alum and other poorly biodegradable materials taken up at the periphery by phagocytes circulate in the lymphatic and blood circulation and can enter the brain using a Trojan horse mechanism similar to that used by infectious particles. Previous experiments have shown that alum administration can cause CNS dysfunction and damage, casting doubts on the exact level of alum safety.”
November 2016: Non-linear dose-response of aluminium hydroxide adjuvant particles: Selective low dose neurotoxicity
Last Fall in 2016, the most important and revealing study yet done on aluminum adjuvant provided more bad news, and more insight.
It’s safe to say that this study’s conclusions have revolutionized our understanding of aluminum adjuvant. From the journal Toxicology, the French study authors were very concerned about the widespread use of aluminum adjuvant:
“Concerns about its [aluminum adjuvant’s] safety emerged following recognition of its unexpectedly long-lasting biopersistence within immune cells in some individuals, and reports of chronic fatigue syndrome, cognitive dysfunction, myalgia, dysautonomia and autoimmune/inflammatory features temporally linked to multiple Al-containing vaccine administrations.”
They also discovered, through mouse-models, a deeply alarming unique characteristic of aluminum adjuvant: low, consistent doses were MORE neurotoxic than a single bolus dose:
“We conclude that Alhydrogel [aluminum adjuvant] injected at low dose in mouse muscle may selectively induce long-term Al cerebral accumulation and neurotoxic effects. To explain this unexpected result, an avenue that could be explored in the future relates to the adjuvant size since the injected suspensions corresponding to the lowest dose, but not to the highest doses, exclusively contained small agglomerates in the bacteria-size range known to favour capture and, presumably, transportation by monocyte-lineage cells. In any event, the view that Alhydrogel neurotoxicity obeys ‘the dose makes the poison’ rule of classical chemical toxicity appears overly simplistic.”
This is a confusing conclusion. The website Vaccine Papers provided further explanation:
“A new paper (Crepeaux et al.) by the Gherardi research group in France reports important results on the toxicity and transport of aluminum (Al) adjuvant in mice. This single study is especially valuable because it looked at many outcomes: behavioral effects, immune (microglial) activation in the brain, and Al transport into the brain. The study tested dosages of 200 , 400 and 800 mcg/Kg, injected intramuscularly (IM). The Al adjuvant used was AlOH (brand name Alhydrogel), the most common vaccine adjuvant in use today. It is used in the tetanus, Hep A, Hep B, HiB, pneumococcal, meningococcal, and anthrax vaccines.
Remarkably, the study found that the lowest dosage (200 mcg/Kg) was the most toxic! For many outcomes, the 400 and 800 mcg/Kg dosages had no observable adverse effects, but the 200 mcg/Kg dosage did.
The low toxicity of the higher dosages appears to be a consequence of dosage-dependent inflammation at the injection site. The high dosages caused intense inflammation at the injection site, forming “granulomas”. The 200 mcg/Kg dosage did not produce granulomas. Granulomas are hard nodules in tissue produced in response to injury, infection or foreign substances. Its a way the body “walls off” injured tissue and prevents the spread of infection or toxins. The granuloma appears to provide protection from Al adjuvant toxicity; apparently the granuloma prevented Al adjuvant particles from leaving the injection site. This explains why the 200 mcg/Kg dosage affected the brain and behavior, while the higher dosages did not. This suggests that it is more dangerous and harmful to administer numerous small injections of Al adjuvant, compared to a large single injection capable of inducing a granuloma.”
The study authors also disputed the way the FDA and CDC currently think about aluminum adjuvant toxicity, basically saying that the current approach is wrong:
“As a possible consequence, comparing vaccine adjuvant exposure to other non- relevant aluminium exposures, e.g. soluble aluminium and other routes of exposure, may not represent valid approaches.”
And, the French scientists finish with a conclusion that all parents should find very troubling:
“In the context of massive development of vaccine-based strategies worldwide, the present study may suggest that aluminium adjuvant toxicokinetics and safety require reevaluation.”
Meet Professor Romain K. Gherardi
There are some true heroes emerging as published research reaches scientific certainty about the vaccine-autism connection, and French researcher Romain K. Gherardi is certainly one of them. Not only were the two studies I just walked you through authored by him, but he appears ready, willing, and able to tell the truth in public, as this recent T.V. appearance demonstrates, just watch (in French with English subtitles):
I’m picturing a press conference with Professor Exley and Professor Gherardi, who’s with me?
2017: Aluminium in brain tissue in autism
The one thing missing from all the work done to date about aluminum and its possible role in autism? Actual brain tissue of people with autism. All the studies published that appeared to be demonstrating strong biological certainty of how the aluminum in vaccines could trigger autism were done with MICE, and Professor Exley and his colleagues’ new research studied the actual brains of people with autism. The conclusions should make you gasp.
“The aluminium content of brain tissues from donors with a diagnosis of ASD [Autism] was extremely high…the mean aluminium content for each lobe across all 5 individuals was towards the higher end of all previous (historical) measurements of brain aluminium content, including iatrogenic disorders such as dialysis encephalopathy …We recorded some of the highest values for brain aluminium content ever measured in healthy or diseased tissues in these male ASD donors…Why, for example would a 15 year old boy have such a high content of aluminium in their brain tissues?”
The answer is pretty obvious
Where’s all this aluminum coming from that Professor Exley and his colleagues just found? What source may have experienced explosive growth in the last three decades, perfectly matching the autism epidemic?
I think the answer is fairly obvious. I think the CDC and public health officials from all over the world have some serious explaining to do.
(Please see below for some more background information.)
J.B. Handley is the father of a child with Autism. He and his wife co-founded Generation Rescue, a national autism charity. He spent his career in the private equity industry and received his undergraduate degree with honors from Stanford University. He is also the author of “Did Chinese scientists find autism’s missing puzzle piece?”, “The Only Vaccine Guide a New Parent Will Ever Need” , “An Angry Father’s Guide to Vaccine-Autism Science”, and “7 reasons CDC employees should be “crying in the hallways”
And another video from Professor Exley back in 2011 discussing aluminum toxicity:
Mr. Handley has started a podcast called “How to End the Autism Epidemic” — you might enjoy his first six interviews: